Tian-Rui Xu Selected Research

Tian-Rui Xu Research Topics

Disease

13	Neoplasms (Cancer) 01/2023 - 12/2013
7	Lung Neoplasms (Lung Cancer) 01/2023 - 07/2015
4	Carcinogenesis 01/2023 - 01/2016
2	Mental Disorders (Mental Disorder) 02/2024 - 01/2021
2	Renal Cell Carcinoma (Grawitz Tumor) 08/2020 - 01/2017
2	Inflammation (Inflammations) 02/2016 - 07/2003
1	Urinary Bladder Neoplasms (Bladder Cancer) 04/2024
1	Epilepsy (Aura) 02/2024
1	Gouty Arthritis 11/2023
1	Gout 11/2023
1	Fibrosarcoma 01/2023
1	Alzheimer Disease (Alzheimer's Disease) 01/2021
1	Pain (Aches) 01/2018
1	Hypoxia (Hypoxemia) 01/2017
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2016
1	Cardiovascular Diseases (Cardiovascular Disease) 02/2016
1	Hypersensitivity (Allergy) 01/2015
1	Substance-Related Disorders (Drug Abuse) 12/2013
1	Obesity 12/2013
1	Feeding and Eating Disorders (Eating Disorder) 12/2013
1	Sleep Initiation and Maintenance Disorders (Insomnia) 12/2013

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2015
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2023 - 01/2015
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2023 - 01/2015
2	ErbB Receptors (EGF Receptor)IBA 01/2022 - 01/2016
2	Mitogen-Activated Protein KinasesIBA 01/2022 - 01/2015
2	raf KinasesIBA 01/2015 - 01/2015
2	Phosphotransferases (Kinase)IBA 01/2015 - 01/2015
1	LipidsIBA 04/2024
1	Thioredoxin Reductase 1IBA 04/2024
1	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2024
1	Cisplatin (Platino)FDA LinkGeneric 04/2024
1	jolkinolide BIBA 04/2024
1	DiterpenesIBA 04/2024
1	ML-162IBA 04/2024
1	GlycosidesIBA 02/2024
1	Uric Acid (Urate)IBA 11/2023
1	BenzbromaroneIBA 11/2023
1	Gout Suppressants (Antigout Agents)IBA 11/2023
1	Acetic Acid (Vinegar)FDA LinkGeneric 11/2023
1	potassium oxonateIBA 11/2023
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2023
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2023
1	Tumor Biomarkers (Tumor Markers)IBA 01/2023
1	osimertinibIBA 01/2022
1	dictamnineIBA 01/2022
1	Gefitinib (Iressa)FDA Link 01/2022
1	Tyrosine Kinase InhibitorsIBA 01/2022
1	Dacarbazine (DIC)FDA LinkGeneric 01/2022
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2022
1	Serotonin ReceptorsIBA 01/2021
1	5-HT1B Serotonin ReceptorIBA 01/2021
1	Therapeutic UsesIBA 01/2021
1	Proto-Oncogene Proteins c-metIBA 01/2021
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 08/2020
1	Small Interfering RNA (siRNA)IBA 01/2019
1	Indicators and Reagents (Reagents)IBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 10/2018
1	Fluorouracil (Carac)FDA LinkGeneric 10/2018
1	Carrier Proteins (Binding Protein)IBA 01/2018
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2018
1	Serine (L-Serine)FDA Link 01/2018
1	AnthracyclinesIBA 01/2017
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2016
1	Lysophosphatidic Acid ReceptorsIBA 01/2016
1	Bombesin Receptors (Bombesin Receptor)IBA 01/2016
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2016
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 01/2016
1	LigandsIBA 01/2016
1	NitrosaminesIBA 07/2015
1	4- (N- methyl- N- nitrosamino)- 1- (3- pyridyl)- 1- butanoneIBA 07/2015
1	CarcinogensIBA 07/2015
1	Peptide Receptors (Peptide Receptor)IBA 12/2013
1	OrexinsIBA 12/2013
1	Orexin Receptor AntagonistsIBA 12/2013
1	Orexin ReceptorsIBA 12/2013
1	EnzymesIBA 07/2003

Therapy/Procedure

7	Therapeutics 04/2024 - 12/2013
2	Drug Therapy (Chemotherapy) 08/2020 - 01/2019
1	Traditional Medicine (Folk Remedies) 02/2024
1	Intraperitoneal Injections 11/2023
1	Injections 11/2023
1	Radiotherapy 01/2019
1	Thoracotomy 03/2016